MA-GILLETTE
Gillette (NYSE: PG), the world’s largest male grooming company and brand pioneer in gaming and esports, proudly announced the return of the highly anticipated Gillette Cup Featuring Fortnite, a two-day international gaming competition featuring a custom-built island in Fortnite. First played in February 2022, the inaugural Gillette Cup garnered over 300,000 viewing hours throughout the tournament. Back for its second year, the event kicks off on June 1, 2023, and will unite members of the Gillette Gaming Alliance as they compete against members of the global Fortnite community for $50,000 -- doubling the prize pool from last year. The Gillette Cup Featuring Fortnite is among one of the largest branded tournaments to date for the gaming community.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230531005178/en/
Gillette celebrates return of Gillette Cup Featuring Fortnite with all-star Gillette Gaming Alliance. (Photo: Business Wire)
The competition will be played on a revamped “Gillette Face-Off” island, a custom environment developed using Fortnite’s Creative toolset; this builds on the success of the island’s existing futuristic lab and mineshaft versions, which were first introduced in 2022. The custom branded Fortnite islands feature action-packed “Zero Build” gameplay and iconic Gillette products for a gaming experience as satisfying as a close shave. To compete in the “Gillette Face-Off” islands at any time, use island code 6674-8139-7577.
“The celebrated return of the Gillette Cup Featuring Fortnite is testament to our previous successes and deepening relationship with Gillette Gaming Alliance members to provide meaningful and impactful experiences to the gaming community,” explains Daniel Ordonez, Gillette Global Brand Franchise Leader. “We are looking forward to cheering on our Alliance members and engaging with Fortnite’s community – while, most importantly, meeting them where they thrive in a truly fun and authentic way.”
For the first time, viewers and fans worldwide can visit www.GilletteCup.com to check out the leaderboard and tune-in for real-time updates. Additionally, they will have the chance to win exclusive Gillette Gaming gear and products by visiting the newly launched website throughout the tournament.
Tournament Details – Competitive, Professional Sporting Event Style Format
The tournament will kick off with the Regionals Round, where eight (8) teams of “Duos,” representing eight (8) countries/regions will compete – totaling 64 teams and 128 players across the globe. Participants will represent Brazil, France, Germany, Italy, Mexico, Spain, United Kingdom, and USA/Canada. Using a points system, teams will be randomly placed on the “Gillette Face-Off” island and compete in multiple rounds of Zero Build matches.
The top 16 teams from Regionals will compete for the opportunity to advance to Semi-Finals and be divided into two (2) groups of eight (8) Duos. These 16 teams will continue to compete in multiple rounds of the “Gillette Face-Off” island. The top four (4) Duos from each group will advance to the Finals to form a single lobby and compete in multiple rounds of the Gillette Cup custom island. The Duos will be scored using the points system and awarded cash prizing, based on how they rank. The last Duo standing will be named winner of the Gillette Cup!
Gillette Gaming Alliance members – inclusive of TypicalGamer (USA/Canada), Vicens (Spain), Agustin (Spain), Papaplatte (Germany), Rumathra (Germany), Elded (Mexico), Jolavanille (France), Pizfn (Italy), Xuider (Italy), Mongraal (United Kingdom), and Nobru (Brazil) – will represent their respective countries as they battle it out against fellow professional members of the Fortnite community to bring home the “win” and championship prize.
“I have had a blast streaming for the Gillette Gaming Alliance this year and providing awesome content and experiences to my community on behalf of the brand,” shares Fortnite pro Andre Rebelo, also known as TypicalGamer, Gillette Gaming Alliance member representing North America. “I remember tuning into the Gillette Cup last year and thinking it was epic. So, I am really excited to be a part of it myself this year – and I hope to bring home the W for my fans and followers.”
The Gillette Gaming Alliance, now in its fifth year, serves as Gillette’s longest running gaming activation as well as one of the most defining and successful programs to date for the brand.
*This is an independently created Fortnite Creative experience and is not sponsored, endorsed, or administered by Epic Games, Inc.
About Gillette
For more than 120 years, Gillette has delivered precision technology and unrivaled product performance – improving the lives of over 800 million consumers around the world. From shaving and body grooming, to skin care and sweat protection, Gillette offers a wide variety of products including razors, shave gel (gels, foams and creams), skin care, after shaves, antiperspirants, deodorants and body wash. For more information and the latest news on Gillette, visit www.gillette.com. To see our full selection of products, visit www.gillette.com. Follow Gillette on Twitter, Facebook and Instagram.
About Procter & Gamble
P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper® The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at www.pg.com/news.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230531005178/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 10:00:00 CET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 10:00:00 CET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 09:00:00 CET | Press release
First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER studyIn MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% vs. 3.2% for placebo), while providing clinically meaningful and statistically significant improvements across all patient-reported outcomesWith longer-term follow-up, 3 out of 4 patients treated with pimicotinib achieved response per RECIST v1.1, and treatment continued to be well-toleratedApproval strengthens Merck’s leadership in rare tumors, with additional ongoing regulatory filings for pimicotinib underway globally Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity.
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom